At 12.4x earnings with a Forward P/E of 14.9, the stock is not priced like a high-growth story, yet it is not statistically distressed either. The PEG of 1.9 suggests the market is discounting limited forward growth, while the Altman Z-Score of 2.6 places the company in a gray zone where balance sheet strength is adequate but not fortress-like. A 0.9 Price/Sales ratio and 2.1 Price/Book imply tangible asset backing, but the modest 5.80% ROE signals underwhelming capital productivity. This is a mid-cycle industrial priced for mediocrity rather than collapse—arguably fair value, but not screamingly cheap unless operational momentum accelerates.
